FOR IMMEDIATE RELEASE
Date: February 2026
Contact: media@ikongroupinvestments.com
Renew Lab Group Expands R&D Capabilities with IKON Group Investment
HOUSTON, TX — IKON Group Investments today announced a significant investment in Renew Lab Group’s research and development infrastructure, including new laboratory equipment, expanded scientific staff, and advanced formulation technology.
The investment positions Renew Lab Group as one of the most advanced independent life science and nutraceutical research laboratories in the Gulf Coast region.
Renew Lab Group’s expanded capabilities will serve both IKON Group’s internal portfolio companies — including Renew Republic Health and Kynetide Peptides — and third-party clients seeking premium contract research and development services.
“Scientific excellence is the foundation of everything we do in our health portfolio,” said Rhett Kenagy. “This investment in Renew Lab Group’s capabilities reflects our long-term commitment to building evidence-based, clinically credible health and wellness products.”
###
About IKON Group Investments: IKON Group Investments is a Houston, Texas-based global holding company managing a diversified over $1 billion portfolio across healthcare, aerospace, biotechnology, real estate, energy, technology, and consumer sectors. For more information, visit ikongroupinvestments.com.